The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

While antipsychotics can be effective for some patients, they come with well-known side effects, including an increased risk ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

About a third of people with schizophrenia are resistant to conventional antipsychotic treatment. The current "pharmaceutical arsenal is limited". Clinical trials for new medications are expensive ...

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

A new study by researchers at the University of Waterloo demonstrates that antipsychotic medications significantly worsened behavior in nursing home residents. “The proportion of long-term care ...

A disproportionately high number of people admitted to long-term care facilities during the COVID-19 pandemic's first year were on antipsychotic medications, recently published Brock-led research ...

All these changes have to be taken into account, and they explain why, for example, elderly persons are more sensitive to benzodiazepine or antipsychotic effects, experiencing stronger sedation ...

A new study conducted by researchers at the University ... It found that residents who were given antipsychotic medications showed a significant worsening of their behaviors.

CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.

Treatment with antipsychotics is very common in the elderly and often indispensable. However, for successful treatment it is essential to have an adequate multidimensional assessment of the ...